Sector: Pharmaceuticals & Biotechnology

Large Cap

AstraZeneca Pharma Share Price

AstraZeneca Pharma India Ltd.

₹8,805

217.50(2.53%)

Invest in ASTRAZEN with up to 2.50x margin.

Trade with MTF

25th May 2026 | 3:14 PM

NSE : ASTRAZEN

Open Free Demat Account

AstraZeneca Pharma Performance

Price Movement

₹8805.00

₹8554.00

₹8895.00

↘ Today's Low↗ Today's High

1 Year Performance

₹8805.00

₹7551.50

₹10691.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹8,895.00

Low₹8,554.00

Open at₹8,609.00

Prev Close₹8,587.50

Volumes9.29 K

Avg Price₹8,773.67

Lower Circuit₹6,870.00

Upper Circuit₹10,305.00

Historical Performance

3M High₹8,949.00

3M Low₹7,551.50

1 Yr High₹10,691.00

1 Yr Low₹7,551.50

3 Yr High₹10,691.00

3 Yr Low₹3,125.00

5 Yr High₹10,691.00

5 Yr Low₹2,445.70

AstraZeneca Pharma Fundamentals

Market Cap

High in industry

21,523.80 Cr.

PE Ratio (TTM)

High in industry

107.10

Dividend Yield

Below industry Median

0.40

Net Profit TTM

107.2% incr over last year

200.89

Net Profit Growth

107.2% incr over last year

200.89

PEG Ratio

Above industry Median

ROE

34% decr over last year

15.02

Operating Revenue TTM

2,177.45

Operating Revenue Growth

34.5% incr over last year

Book Value

High in industry

25.90

MFI

MFI is mid-range

60.64

RSI

RSI is mid-range

56.25

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

25.90

AstraZeneca Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	611.57	559.09	526.31	480.48	440.29
Operating Expense	566.74	483.91	445.20	394.11	363.47
Operating Profit	44.83	75.18	81.11	86.37	76.99
Depreciation	3.84	2.57	16.57	17.69	9.07
Interest	1.06	0.67	0.72	0.68	0.33
Tax	13.95	18.60	18.87	20.22	11.17
Net Profit	32.59	54.22	55.83	58.25	30.85

AstraZeneca Pharma Technicals

AstraZeneca Pharma India Ltd. EMA & SMA

₹8805.00

109.50 (1.26%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹8556.7

Day EMA10 ₹8498.7

Day EMA12 ₹8484.1

Day EMA20 ₹8446.2

Day EMA26 ₹8432.5

Day EMA50 ₹8443.4

Day EMA100 ₹8537.8

Day EMA200 ₹8554

AstraZeneca Pharma Support and Resistance

Resistance

First Resistance₹8756.33

Second Resistance₹8903.17

Third Resistance₹8991.33

Support

First Support₹8521.33

Second Support₹8433.17

Third Support₹8286.33

Technical Indicators

Day RSI56.25

Day MFI60.64

Day ADX14.62

Day Commodity Channel Index147.40

William-25.53

Day MACD51.60

Day MACD Signal Line24.98

Day ATR239.60

Day ROC125-5.94

Day ROC210.91

AstraZeneca Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	75	75	75	75	75	75
FII	2.9	2.9	3	2.7	2.7	2.8
DII	5.2	4.6	4.6	5.3	5.6	5.8
Public	16.8	17.4	17.4	17	16.7	16.4

AstraZeneca Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	3.67 K	6.14 K	59.67%
Week	2.29 K	4.43 K	51.63%
1 Month	3.08 K	6.06 K	50.80%
6 Month	4.67 K	9.51 K	49.09%

AstraZeneca Pharma SWOT Analysis

Strengths13

Weakness6

Opportunity5

Threats1

Companies with no Debt

Benjamin Graham Value Screen

Consistent high performing stocks over Five Years

Rising Net Cash Flow and Cash from Operating activity

Expensive Performers (DVM)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Increasing Revenue every Quarter for the past 8 Quarters

Increasing Revenue every Quarter for the past 4 Quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Volume Shockers

AstraZeneca Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Jul, 2025	32	FINAL	18 Jul, 2025	Equity Share
05 Jul, 2024	24	FINAL	05 Jul, 2024	Equity Share
14 Jul, 2023	16	FINAL	14 Jul, 2023	Equity Share
07 Jul, 2022	8	FINAL	08 Jul, 2022	Equity Share
18 Aug, 2021	2	INTERIM	20 Aug, 2021	Equity Share
20 Aug, 2020	2	INTERIM	21 Aug, 2020	Equity Share
20 Aug, 2019	1	INTERIM	21 Aug, 2019	Equity Share
09 Jul, 2012	3.5	FINAL		Equity Share
07 Jul, 2011	10	FINAL		Equity Share
06 May, 2010	10	FINAL		Equity Share

AstraZeneca Pharma Stock Comparison

Financials	Anthem Biosciences Ltd.	Lupin Ltd.	Dr. Reddy's Laboratories Ltd.	Cipla Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.
Price (₹)	₹765.70	₹2,291	₹1,333	₹1,414.60	₹1,175.20	₹1,800.10
% Change	-1.47%	0.40%	1.97%	1.10%	5.51%	-1.88%
Revenue TTM (₹ Cr)	₹2,124.33	₹27,958.03	₹33,700.20	₹28,162.59	₹2,192.49	₹1,421.59
Net Profit TTM (₹ Cr)	₹591.79	₹5,332.84	₹4,196	₹3,879.23	₹348.91	₹-73.80
PE TTM	74.10	19.60	26.30	29.10	69.40	-290.10
1 Year Return	36.93	12.61	8.44	-6.17	52.37	14.63
ROCE	27.56	30.58	13.90	15.65	18.38	0.59

Similar Stocks

EMCURE

Emcure Pharmaceuticals Ltd.

₹ 1740.00

+1.54%

MANKIND

Mankind Pharma Ltd.

₹ 2457.50

-0.88%

PPLPHARMA

Piramal Pharma Ltd.

₹ 179.26

+2.07%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2918.90

-1.09%

GLAND

Gland Pharma Ltd.

₹ 2336.30

+0.10%

LAURUSLABS

Laurus Labs Ltd.

₹ 1357.00

+1.00%

ALKEM

Alkem Laboratories Ltd.

₹ 5401.00

-0.06%

BIOCON

Biocon Ltd.

₹ 429.85

-0.09%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6763.00

-1.80%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3087.60

-0.64%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1074.20

+3.39%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2336.40

+3.42%

WOCKPHARMA

Wockhardt Ltd.

₹ 1636.80

+3.90%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1453.10

-0.71%

NATCOPHARM

Natco Pharma Ltd.

₹ 1174.00

+0.37%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1840.70

-0.21%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 16740.00

+0.28%

IPCALAB

Ipca Laboratories Ltd.

₹ 1571.30

-1.92%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2224.00

+1.43%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2300.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4699.30

+0.61%

ABBOTINDIA

Abbott India Ltd.

₹ 27700.00

-0.47%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4573.40

+1.94%

FAQ's on ASTRAZEN

What is the current share price of AstraZeneca Pharma India Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for AstraZeneca Pharma India Ltd. is ₹ 8805 on the NSE and ₹ 8821.35 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of AstraZeneca Pharma India Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for AstraZeneca Pharma India Ltd. is approximately ₹ 21523.8 Cr.

What are the PE and PB ratios for AstraZeneca Pharma India Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for AstraZeneca Pharma India Ltd. is 107.1, and the Price-to-Book (PB) ratio is 25.9.

What is the 52-Week High and Low for AstraZeneca Pharma India Ltd.?

Over the past 52 weeks, the highest price reached by AstraZeneca Pharma India Ltd. shares was ₹ 10691, and the lowest price was ₹ 7551.5.

What is the current dividend yield for AstraZeneca Pharma India Ltd.?

As of 6 June 2025, the dividend yield for AstraZeneca Pharma India Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of AstraZeneca Pharma India Ltd.?

Significant shareholdings in AstraZeneca Pharma India Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of AstraZeneca Pharma India Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, AstraZeneca Pharma India Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for AstraZeneca Pharma India Ltd.?

AstraZeneca Pharma India Ltd. last declared a FINAL dividend of ₹ 32 per share for the financial period ending 2025. The record date was set as 2025-07-18, and the payment was/is scheduled around 2025-07-18. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy